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Background: Population-based studies for prevalence of metabolic syndrome (M.S) in children and adolescents are
relatively rare. The aim of this study was to assess the Prevalence of M.S and correlated factors among children and
adolescents aged 10 to 19 years in Ahvaz.
Methods: In this descriptive-analytical population- based study, 2246 children and adolescents, 10–19 years old
(1113 male and 1133 female) in Ahvaz, were evaluated. Anthropometry, biochemical measurement and blood
pressure (BP) were assessed. Modified ATP III criteria 2005 were used for M.S. definition. Center for disease and
Control preventions (CDC) percentile were applied to define cut off points of waist circumference and BP.
Results: Prevalence of M.S. was 9% (95% CI: 8-10%) with prevalence in male 11% (95% CI: 10-12%) and female 7%
(95% CI 6-8%). Among individuals with M.S, triglyceride (TG) and decreased high density lipoprotein (HDL) cholesterol
levels were the most common components (33.5% and 24.1%, respectively). Prevalence of M.S was higher in overweight
persons comparing to participants with at risk and normal weight group (in male: 24.1%, 14.3% and 9.9% respectively
P = 0.0001), (in female: 22.6%, 18.3% and 4.5% respectively P = 0.0001). Among the correlated factors of M.S age
(P = 0.0006), sex and BMI (P = 0.0001) had significant differences between subjects with and without M.S. whereas
there was no significant difference between two groups in ethnicity, history of breast fed, birth weight neonatal
ICU admission, maternal history(GDM, gestational HTN, Parity) and family history of HTN, obesity and DM (P > 0.05).
Conclusion: This study shows high prevalence of M.S in Children and Adolescents in south west of Iran (Ahvaz)
especially in overweight persons.
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Since early 1960s, an association between obesity and ele-
vated level of triglycerides (TG), decreased level of high-
density lipoprotein (HDL) cholesterol, hyperinsulinemia,
impaired glucose tolerance, high blood pressure (BP) and
cardiovascular disease, (CVD) has been discussed. For first
time it was introduced in 1988 by Reaven et al. as meta-
bolic syndrome (M.S) [1]. M.S is the risk factor of all cause
and C.V. mortality in adults with and without type 2
diabetes [2]. According to some studies, M.S could be* Correspondence: peyman_payami1@yahoo.com
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reproduction in any medium, provided the ororiginated from embryonic period [3,4]. Although the
prevalence of M.S and its risk factors have been widely
studied in adults, limited studies are available in children
and adolescents so that there is no clear definition of M.S
in this age group. Therefore more studies are required to
provide a better definition of M.S in children and adoles-
cents. Currently, the same risk factors of adults are used in
this age group based on age and gender percentiles from
global or rational data or study specific distributions. Based
on limited studies 4.2% of the American children and ado-
lescents who participated in the NHANES III 1988-1994
had M.S. [5]. That increased to 6.2% in NHANES 1999–
2000 [6]. As the prevalence of overweight in American chil-
dren and adolescents increase [7], the prevalence of M.S isLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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32% of overweight subjects had M.S., respectively. As well,
a recent study in Tehran revealed that the prevalence of
overweight in Iranian children and adolescents was high
with an estimated prevalence of 21% [8]. On the other
hand, in another study in Tehran, the prevalence of M.S in
children and adolescents was estimated about 10% based
on modified ATPIII criteria [9]. These studies indicated
that the prevalence of M.S is significantly higher in more
obese subjects. Recently, the prevalence of M.S has been
reported among Mexican [10], Tunisian [11], Indian [12]
and Chinese [13] children and adolescents. Different gen-
etic, racial [14] and environmental factors like lifestyle,
change of lifestyle from rural to urban, physical activity
and socioeconomic conditions play significant role in the
prevalence of M.S. Therefore, this study was designed to
determine the prevalence of M.S and its risk factors
among children and adolescents of Ahvaz aged 10–
19 years old.
Materials and methods
This descriptive-analytic study performed in Ahvaz, cap-
ital city of Khuzestan province (South West of Iran) in
2009–2011. Of 25 health centers, 6 ones were selected
randomly by multi-steps cluster sampling method. In-
formed written consent was obtained from subjects aged
10–19 and parents of subjects under the age of 19. A
questionnaire including age, sex, ethnicity, birth weight,
history of breast feeding, neonatal ICU admission, history
of pregnancy in participant’s mother [gestational diabetes
mellitus (GDM), gestational hypertension and parity num-
ber], family history of diabetes mellitus (DM), hyperten-
sion (HTN) and obesity was filled for each subject. In this
study after excluding subjects taking medication that
would affect serum lipids, blood pressure and carbohy-
drate metabolism and subjects with history of chronic dis-
ease, of heart, lung, kidney and liver and chronic diarrhea
and hospitalization during three months ago, individual
with full relevant data were included. Blood pressure was
measured twice at least 30 minutes apart by an appropri-
ate mercury sphygmomanometer after 15 minutes rest in
a sitting position. The mean of the two readings was re-
corded as individual blood pressure.
Waist circumference was measured at the midpoint of
the lowest rib and iliac crest over light clothing at the end
of exhalation using a tape measure. Heights and weights
were measured, using a tape measure in a standing pos-
ition with bare feet and seca scales with minimum possible
clothing, respectively. Body mass index (BMI) [weight
(Kg)/Height (m) 2] was calculated for each subject. Blood
samples were drawn after a 12- hour overnight fasting.
About 30–45 minutes after sampling, the samples were
centrifuged by 2500–3000 rpm for 10 minutes; sera
were stored in refrigerator and then sent to laboratory.Fasting blood sugar (FBS), TG, total cholesterol and
HDL cholesterol were measured by enzyme-calorimetric
method using Pars Azmoon kits (with biotechnical instru-
ments type BT-3000 Germany). Modified ATP III criteria
2005 [5,6] were used to define M.S as follows:
1- Abdominal obesity (waist circumference ≥ the age
and sex specific 90th percentile using C.D.C
percentiles)
2- Elevated BP(systolic and/or diastolic blood
pressure ≥the age and sex -specific 90the percentile
using C.D.C percentiles except for 18 and 19 years
old subjects, for whom the cut off values of ≥130
and/or ≥85 mmHg for systolic and diastolic blood




Subjects with 3 or more characteristics of the above
components were categorized as M.S.
Overweight, at risk for Overweight and normal weight
were defined based on the study specific percentile curves
of BMI for age and sex as ≥95th percentile, ≥85 to <95th
percentile and <85th percentile, respectively.
Descriptive statistics were used to prepare graphs and
tables. Chi -Square test was applied to compare ratios
and multivariate logistic regression analysis was used to
determine the potential determinants of M .S.
P < 0.05 was considered as significant. All data were
analyzed by SPSS software version 19.
Results
A total of 2246 children and adolescents (1120 boys, 1139
girls) aged 10–19 participated in our investigation. Baseline
characteristics of study population according to sex is
shown in Table 1. According to the modified ATPIII cri-
teria,the prevalence of M.S was 9% (95% CI: 0.08-0.10). The
prevalence of MS in boys [11% (95% CI: 10-12%)] was sig-
nificantly higher than girls [7% (95% CI: 6-8%)], (P==0.001)
(Table 2). In both gender, the prevalence of MS was differ-
ent between age groups. The prevalence of MS decreases
approximately after the age of 10 to 11 while it increases
after the age 14 and highest rate was observed at ages 16
to17. In boys, the relationship between the prevalence of
M.S and increase of age was insignificant (P = 0.403) but it
was significant in girls (P = 0.010) (Figure 1).
When examined by BMI category, overweight group
had a higher prevalence of MS than at risk for overweight
and normal weight groups (P = 0.0001) (Table 3).
In this study, 46% and 5% of the participants with a
waist circumference ≥90th percentile and <90% percentile
had M.S respectively (P = 0.0001). The mean of waist cir-
cumference between two genders showed significant
Table 1 Basic characteristics of the study population
according to sex
Variable Male Female P value
Age (year) 14.63 ± 2.58 15.27 ± 2.74 0.0001
Height (cm) 162.83 ±v13.82 151.81 ± 9.32 0.0001
Weight (Kg) 52.39 ± 14.69 50.99 ± 12.39 0.015
BMI (Kg/m2) 19.75 ± 4.43 20.83 ± 4.20 0.0001
Waist circumference (cm) 70.69 ± 11.23 68.19 ± 9.82 0.0001
HDL (mg/dl) 53.77 ± 12.18 55.62 ± 11.77 0.0001
TG (mg/dl) 111.62 ± 67.07 100.52 ± 57.66 0.0001
SBP (mm Hg) 106.58 ± 11.25 106.32 ± 10.99 0.574
DPB (mm Hg) 60.65 ± 10.20 64.85 ± 9.68 0.0001



























Figure 1 Prevalence of Metabolic syndrome in different sex
and age groups.
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nent of M.S in subjects with M.S was: abdominal obesity
10.3% elevated BP 22.1%, low HDL-cholesterol 24.1%, high
TG 33.5% and high FBS 16.4% (Table 4). In subjects with
M.S., 81.8% had three components of M.S, 16.7% had four
and 1.5% had five ones. In the whole study population,
36.5% were normal (no components of M.S), 34.6% had
one. 19.9% Two, 7.3% three, 1.5% four and 0.1% had five
components.
Factors that can affect the prevalence of M.S are seen in
Table 5. Among the correlated factors of M.S age (P =
0.006), sex and BMI (P = 0.0001) had significant differ-
ences between subjects with and without M.S. whereas
ethnicity, breast feeding, birth weight, neonatal ICU ad-
mission, maternal history (GDM, Gestational HTN, Parity
no) and family history of HTN, obesity and D.M had no
differences (P > 0.05).Table 2 Prevalence of M.S in different sex and age groups









10 94 11 (11.7) 45 6 (13.3) 49 5 (10.2)
11 208 24 (11.5) 124 12 (9.7) 84 12 (14.3)
12 239 21 (8.8) 137 16 (11.7) 102 5 (4.9)
13 163 9 (5.5) 87 5 (5.7) 76 4 (5.3)
14 243 23 (9.5) 119 12 (10.1) 124 11 (8.9)
15 299 25 (8.4) 147 14 (9.5) 152 11 (7.2)
16 272 35 (12.9) 151 21 (13.9) 121 14 (11.6)
17 236 30 (12.7) 128 21 (16.4) 108 9 (8.3)
18 227 13 (5.7) 98 10 (10.2) 129 3 (2.3)
19 265 12 (4.5) 77 6 (7.8) 188 6 (3.2)
Total 2246 203 (9) 1113 123 (11.1) 1133 80 (7.1)
P Value 0.0006 0.0403Discussion
In this study, the prevalence of M.S among children and
adolescents aged 10–19 was 9% based on the modified
ATPIII 2005 criteria which was significantly higher in boys
than girls (P = 0.001). The prevalence of M.S in our study
was similar to the study of Esmailzadeh et al. [9] in Tehran
based on same criteria. In that report, prevalence of M.S
was not significantly different between boys and girls and
study- specific distributions to define thresholds of risk fac-
tors were used. In another study in Tehran by Chiti et al.
[15], the prevalence of M.S among children and adolescents
aged 10–19 was 9.5% based on the same criteria which was
higher in boys than girls. The result of that study was con-
sistent with ours. Kelishadi et al. [16] conducted another







M.S (%) P value
Total Normal (<85) 1911 (85.1) 7.2
0.0001At risk (85-95) 227 (10.1) 16.3
Overweight (≥95) 108 (4.8) 26.9
Male Normal (<85) 946 (85.1) 9.9
0.003At risk (85-95) 112 (10.1) 14.3
Overweight (≥95) 54 (4.9) 24.1
Female Normal (<85) 946 (85.1) 4.5
0.0001At risk (85-95) 115 (10.2) 18.3
Overweight (≥95) 54 (4.8) 29.6
Table 4 Prevalence of individual component of metabolic syndrome according to age and sex among subjects with
metabolic syndrome
Age (year) Abdominal obesity (%) TG ≥ 110 (%) HDL ≤ 40 (%) BP ≥ 130/85 (%) FBS ≥ 100 (%)
Total population
10 9.7 34 18.1 36.2 21.3
11 11.4 34.6 17.3 34.6 19.2
12 10.3 35.2 20.9 24.3 18.6
13 9.4 37.7 19 16 14.2
14 10.2 33.3 27.2 21.4 25.1
15 9.6 36.7 27.8 26.1 11.2
16 10.7 31.8 30.5 36.4 15.4
17 10 40.6 28 25.4 15
18 11.1 26.3 21.1 3.1 12.5
19 10 26.1 23.1 3.8 14.9
Total 10.3 33.5 24.1 22.1 16.4
Males
10 11.1 31.1 11.1 24.4 22.2
11 9.7 33.9 15.3 33.9 18.5
12 11.1 34.8 19.7 35 21.3
13 9.3 37.2 14.9 16.1 17.4
14 9.5 34.5 26.1 24.4 30.3
15 9.7 40.3 31.3 27.9 13.9
16 10.6 36.1 37.1 35.8 15.6
17 9.6 48.4 32.8 24.2 15.6
18 11.5 32 35.7 5.1 17.5
19 10.4 36.8 36.4 3.9 23.7
Total 10.2 37.1 27.1 25 19.1
Females
10 8.3 36.7 24.5 46.9 20.4
11 14.1 35.7 20.2 35.7 20.2
12 9.2 35.6 22.5 9.8 14.9
13 9.5 38.2 23.7 15.8 10.5
14 10.8 23.3 27.2 18.5 20.2
15 9.5 33.3 24.3 38.2 8.7
16 10.7 26.7 22.3 37.2 15
17 10.5 31.1 22.2 26.9 14.2
18 10.9 22 10.1 1.6 8.7
19 9.8 21.6 17.6 3.7 11.4
Total 10.3 29.9 21.1 19.3 13.6
TG: Trigliceride, HDL-D: high density lipoprotein cholesterol, BP: blood pressure, FBS: fasting blood suger.
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with above- mentioned studies.
Other studies in different cities of Iran [17-19], not
population- based, could not reflect the whole society.
Population - based epidemiologic studies in other coun-
tries have shown various prevalence rates. In the U.S, the
prevalence of M.S among children and adolescents hasbeen reported 3.1% to 12.7% with different definitions and
cut off points [20]. These studies have revealed that the
prevalence of M.S. is increasing by time in this age group.
The investigation of Herrabi et al. [11] in Tunisia showed
that the prevalence of M.S. is 4% in urban regions based
on the modified -ATPIII criteria. Overweight and obesity
were the most common components of the syndrome. In
Table 5 Risk factors of metabolic syndrome among children and adolescences
B S.E P value OR Confidence interval (CI)
Sex (M/F) 0.643 0.178 0.000 1.903 1.341-2.700
Ethnicity (Arab/Fars) -0.019 0.174 0.914 0.981 0.698-1.380
Birth weight 0.207 0.139 0.135 1.230 0.937-1.614
Neonatal nutrition (breastfeeding/other) 0.003 0.617 0.991 1.003 0.630-1.596
ICU Admission 0.356 0.508 0.483 1.428 0.528-3.863
Family history
Obesity 0.087 0.183 0.647 1.087 0.760-1.555
Diabetes 0.430 0.223 0.054 1.523 0.993-2.380
HTN 0.278 0.226 0.204 1.333 0.856-2.076
Maternal history
Parity no. 0.045 0.042 0.286 1.046 0.963-1.136
GDM -0.305 0.508 0.548 0.737 0.273-1.994
Gestational HTN 0.362 0.360 0.314 1.437 0.709-2.910
BMI
BMI 85-95/BMI<85 0.970 0.243 0.001 2.639 1.640-4.248
BMI≥95/BMI<85 1.645 0.303 0.001 5.180 2.859-9.387
Age (Year)
11/10 -0.381 0.429 0.374 0.683 0.295-1.583
12/10 -0.326 0.415 0.432 0.722 0.320-1.628
13/10 -0.945 0.490 0.054 0.389 0.149-1.017
14/10 -0.556 0.426 0.192 0.573 0.249-1.322
15/10 -0.672 0.420 0.109 0.511 0.224-1.163
16/10 -0.244 0.403 0.546 0.784 0.356-1.728
17/10 -0.493 0.422 0.243 0.611 0.267-1.397
18/10 -1.196 0.473 0.011 0.302 0.120-0.763
19/10 -1.875 0.519 0.000 0.153 0.056-0.424
S.E: Stanndard error.
B: coefficient of variable.
O.R: Odd ratio.
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prevalence of M.S to be 4.2% using modified ATPIII cri-
teria. That study again confirmed that the prevalence of
M.S is higher in at risk for overweight and overweight per-
sons. A study in Mexico by Rodrignes -Moran et al. [11]
using modified ATP III criteria showed prevalence of M.S.
to be 6.5% while it was 4.5% by WHO criteria. As well, an
investigation in China by Liet of [13] using the criteria
proposed by Ferranti et al. [20], reported the prevalence of
M.S to be 3.7%. According to that study, it is estimated
that 3 million children and adolescents have M.S in China.
The lack of a comprehensive and clear definition of M.S in
children and adolescents could explain to some extent.
The difference of prevalence rates reported in various
studies throughout the world. On the other hand, the fac-
tors like various prevalence of overweight, race, genetic
factors, change in lifestyle from rural to urban, physical activ-
ity level and socioeconomic condition could be considered.Like other studies in Iran [8,19,21], our investigation showed
a higher prevalence of M.S. among at risk for overweight
and overweight children and adolescents in both genders.
On the other hand, the prevalence of overweight in Iranian
children has been reported to be up to 8%. The change of
nutritional style in Iranian children and adolescents is
probably an important reason for the uprising problem of
overweight and M.S. As well, some evidences are available
that indicates decrease in physical activity of Iranian chil-
dren and adolescents [22,23]. Moreover, recent epidemio-
logical studies show a parallel increase in type 2 diabetes
mellitus in children/adolescents and obesity [24,25]. Unfor-
tunately, the rise in prevalence of M.S. and type 2 D.M in
children and adolescence lead to an increase in correlated
complications in young adults, including early C.V.D [20].
The current study has several strengths. It was a
population- based study with a relatively large sample size.
Moreover numerous correlated factors were assessed. One
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a definition for children and adolescents has been dis-
cussed previously [5,20,26]. Cross sectional nature of
this study was the other limitation that did not allow us
to make causal inference. Our study provides evidences
showing a high prevalence of M.S. among Iranian chil-
dren and adolescents, especially in overweight subjects.
In the future, large prospective studies should be con-
ducted to confirm the association between above- men-
tioned factors and M.S.
Conclusion
Among the factors correlated to M.S., age, sex and BMI
were significantly different between subjects with and with-
out M.S. whereas ethnicity, breast feeding, birth weight,
neonatal ICU admission, maternal history (GDM, gesta-
tional hypertension, parity number) and family history of
hypertension, obesity and diabetes mellitus did not show
significant differences.
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